Cas:756521-08-1 3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-2-nitropyridine manufacturer & supplier

Chemical Name:3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-2-nitropyridine

CAS.NO:756521-08-1

Synonyms:Pyridine, 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-2-nitro-;3-(2,6-dichloro-3-fluoro-benzyloxy)-2-nitro-pyridine;I14-9765;3-[1-(2,6-dichloro-3-fluoro-phenyl)-ethoxy]-2-nitro-pyridine;3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-2-nitropyridine

Molecular Formula:C₁₃H₉Cl₂FN₂O₃

Molecular Weight:331.127

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:459.6±40.0 °C at 760 mmHg

Density:1.5±0.1 g/cm3

Index of Refraction:1.597

PSA:67.94000

Exact Mass:329.997437

LogP:4.05

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Pyridine, 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-2-nitro- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-2-nitropyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(2,6-dichloro-3-fluoro-benzyloxy)-2-nitro-pyridine Use and application,Pyridine, 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-2-nitro- technical grade,usp/ep/jp grade.

Related News: The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant��s collection. 3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-2-nitropyridine manufacturer The FDA said its decision allows for the J&J doses to be used in the United States or exported. T 3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-2-nitropyridine supplier The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant��s collection. 3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-2-nitropyridine vendor From the perspective of product structure, the varieties of these enterprises are mainly concentrated in vitamins, antipyretics and analgesics, antibiotics and corticosteroids (ie bulk drug substances). 3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-2-nitropyridine factory It is estimated that the size of China’s CMO market has reached about USD 5 billion. With the implementation and further implementation of the MAH system (the core is to separate drug marketing authorization from drug production authorization) in China, it is expected to promote the outbreak of the domestic drug CMO industry. It will grow at a rate of 20% to 30%, of which patented APIs occupy a larger proportion.